The National Network of Depression Centers: Progress through partnership

Depression and Anxiety

Volumn 28, Issue 8, 2011, Pages 615-621

  Paulus, John F ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; MOOD STABILIZER;

ARTICLE; BIPOLAR DISORDER; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; EDITOR; ELECTROCONVULSIVE THERAPY; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; INTEGRATION; MAJOR DEPRESSION; MEDICAL EXPERT; MEDICAL LITERATURE; MENTAL HEALTH CENTER; MOTIVATION; MULTICENTER STUDY (TOPIC); NATIONAL NETWORK OF DEPRESSION CENTER; OUTCOME ASSESSMENT; PEER REVIEW; PHYSICIAN; PRIORITY JOURNAL; PSYCHIATRY; PUBLIC-PRIVATE PARTNERSHIP; PUBLICATION; RISK FACTOR; TRANSCRANIAL MAGNETIC STIMULATION; UNIVERSITY HOSPITAL;

BIPOLAR DISORDER; DEPRESSIVE DISORDER; HUMANS; MENTAL HEALTH SERVICES; PUBLIC HEALTH; PUBLIC-PRIVATE SECTOR PARTNERSHIPS; UNITED STATES;

EID: 79960961407     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.20862     Document Type: Article

References (28)

1. Kessler RC, Chiu WT, Demler O, Walters EE,. Prevalence, severity and comorbidity of twelve-month DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R). Arch Gen Psychiatry 2005; 62: 617-627. (Pubitemid 40973437)
2. Greden JF,. The burden of disease for treatment-resistant depression. J Clin Psychiatry 2001; 16: 26-31.
3. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ,. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367: 1747-1757. (Pubitemid 43767064)
4. World Health Organization: The Global Burden of Disease 2004 Update. 2008. Available at:. Accessed September 16, 2010.
5. Gibbons RD, Hur K, Bhaumik DK, Mann JJ,. The relationship between antidepressant medication use and rate of suicide. Arch Gen Psychiatry 2005; 62: 165-172. (Pubitemid 40189132)
6. Greden JF, Riba M, McInnis, editors. Treatment Resistant Depression: A Roadmap for Effective Treatment (Review of Psychiatry Series;, Oldham JM, and, Riba MB, series, editors). Washington, DC: American Psychiatric Press; 2011.
7. Amara SG, Grillner S, Insel T, Nutt D, Tsumoto T,. Neuroscience in recession? Nat Rev Neurosci 2011; 12: 297-302.
8. Crowley Jr WF, Sherwood L, Salber P, Scheinberg D, Slavkin H, Tilson H, Reece EA, Catanese V, Johnson SB, Dobs A, Genel M, Korm A, Reame N, Bonow R, Grebb J, Rimoin D,. Clinical research in the United States at a crossroads: proposal for a novel public-private partnership to establish a national clinical research enterprise. J Am Med Assoc 2004; 291: 1120-1126. (Pubitemid 38541690)
9. Andrews G, Issakidis C, Sanderson K, Corry J, Lapsley H,. Utilising survey data to inform public policy: comparison of the cost-effectiveness of treatment of ten mental disorders. British Journal of Psychiatry 2004; 184: 526-533. (Pubitemid 38725713)
10. Katon WJ,. Collaborative care: evidence-based models that improve primary care depressive outcomes. CNS Spectr 2009; 14: 10-14.
11. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramani GK, Fava M,. Evaluation of outcomes with citalpopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006; 163: 28-40. (Pubitemid 43050100)
12. March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Clinical Coordinating Center, Duke Clinical Research Institute, Duke University Medical Center, Vitiello B, Severe J, NIH. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression. Treatment for Adolescent Depression Study (TADS) randomized controlled trial. J Am Med Assoc 2004; 292: 807-820. (Pubitemid 39079667)
13. Insel TR, Wang PS,. The STAR*D trial: revealing the need for better treatments. Psychiatr Serv 2009; 60: 1466-1467.
14. Unutzer J,. Evidence-based treatments for anxiety and depression: lost in translation. Depress Anxiety 2008; 25: 726-729.
15. American Cancer Society. Cancer Facts & Figures 2010, Estimated New Cancer Cases and Deaths by State, US, Atlanta, GA: American Cancer Society; 2010, p4. Retrieved May 26, 2011 from
16. "Cancer Institute's New Chief Talks of Cutbacks." New York Times August 17, 2006.
17. Horner MJ, Ries LAG, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Eisner MP, Horner MJ, Howlader N, Hayat M, Hankey BF, Edwards BK,. (eds). Surveillance epidemiology and end results (SEER) cancer statistics review 1975-2006, based on November 2008 SEER data submission, posted to the SEER web site, 2009. Table 2.18: "Estimated United States Cancer Prevalence Counts on January 1, 2006", All Cancer Sites (Invasive): prevalence within past 5 years. National Cancer Institute. Bethesda, MD
18. Zisook S, Lesser I, Stewart JW, Wisniewski SR, Balasubramani GK, Fava M, Gilmer WS, Dresselhaus TR, Thase ME, Nierenberg AA, Trivedi MH, Rush AJ,. Effect of age at onset on the course of major depressive disorder. Am J Psychiatry 2007; 164: 1539-1546. (Pubitemid 350069733)
19. Judd LL, Paulus MJ, Schettler PJ, Akiskal HS, Endicott J, Leon AC, Maser JD, Mueller T, Solomon DA, Keller MB,. Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? Am J Psychiatry 2000; 157: 1501-1504.
20. Greden JF, editor. Treatment of recurrent depression (Review of Psychiatry Series Vol 20;, Oldham JM, Riba MB, editors). Washington, DC: American Psychiatric Press; 2001.
21. Geddes JR, Carney SM, Davies C, Furukawa TA, Kupfer DJ, Frank E, Goodwin GM,. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 2003; 361: 653-661. (Pubitemid 36246547)
22. Reynolds CF, Dew MA, Pollock BG, Mulsant BH, Frank E, Miller MD, Houck PR, Mazumdar S, Butters MA, Stack JA, Schlernitzauer MA, Whyte EM, Gildengers A, Karp J, Lenze E, Szanto K, Bensasi S, Kupfer DJ,. Maintenance treatment of major depression in old age. N Engl J Med 2006; 354: 1130-1138.
23. Golberstein E, Eisenberg D, Gollust SE,. Perceived stigma and mental health care seeking. Psychiatr Serv 2008; 59: 392-399.
24. Berwick DM,. Disseminating innovations in health care. J Am Med Assoc 2003; 289: 1969-1975. (Pubitemid 37430229)
25. Cuijpers P, van SA, Smit F, Mihalopoulos C, Beekman A,. Preventing the onset of depressive disorders: a meta-analytic review of psychological interventions. Am J Psychiatry 2008; 165: 1272-1280.
26. Goodman WK, Insel TR,. Deep brain stimulation in psychiatry: concentrating on the road ahead. Biol Psychiatry 2009; 65: 263-266.
27. Mathew SJ, Manji HK, Charney DS,. Novel drugs and therapeutic targets for severe mood disorders. Neuropsychopharmacology 2008; 33: 2080-2092. (Pubitemid 351992096)
28. National Child Traumatic Stress Network (NCTSN). The NCTSN mission and vision. Retrieved July 10, 2009, from